Stifel's Paul Matteis joins BiotechTV for Analyst Thursdays from Boston
He provides an in-depth discussion on this week's uniQure data, and upcoming data from Lexeo. Plus, comments on Alnylam, Dyne, Neurocrine, Alector, Neumora, Alto Neuroscience, and Neurogene.